- Home
- FEBO vs CLDI Comparison
FEBO vs CLDI Comparison
Compare FEBO & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEBO
- CLDI
- Stock Information
- Founded
- FEBO 1993
- CLDI 2014
- Country
- FEBO Hong Kong
- CLDI United States
- Employees
- FEBO N/A
- CLDI N/A
- Industry
- FEBO
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FEBO
- CLDI Health Care
- Exchange
- FEBO Nasdaq
- CLDI Nasdaq
- Market Cap
- FEBO 19.4M
- CLDI 18.1M
- IPO Year
- FEBO 2023
- CLDI N/A
- Fundamental
- Price
- FEBO $1.47
- CLDI $0.76
- Analyst Decision
- FEBO
- CLDI Strong Buy
- Analyst Count
- FEBO 0
- CLDI 3
- Target Price
- FEBO N/A
- CLDI $16.67
- AVG Volume (30 Days)
- FEBO 57.8K
- CLDI 1.2M
- Earning Date
- FEBO 10-03-2024
- CLDI 03-14-2025
- Dividend Yield
- FEBO N/A
- CLDI N/A
- EPS Growth
- FEBO N/A
- CLDI N/A
- EPS
- FEBO N/A
- CLDI N/A
- Revenue
- FEBO $16,319,897.00
- CLDI N/A
- Revenue This Year
- FEBO N/A
- CLDI N/A
- Revenue Next Year
- FEBO N/A
- CLDI N/A
- P/E Ratio
- FEBO N/A
- CLDI N/A
- Revenue Growth
- FEBO 9.01
- CLDI N/A
- 52 Week Low
- FEBO $1.20
- CLDI $0.69
- 52 Week High
- FEBO $17.68
- CLDI $16.80
- Technical
- Relative Strength Index (RSI)
- FEBO 41.24
- CLDI 29.25
- Support Level
- FEBO $1.54
- CLDI $0.83
- Resistance Level
- FEBO $1.72
- CLDI $0.94
- Average True Range (ATR)
- FEBO 0.21
- CLDI 0.12
- MACD
- FEBO -0.00
- CLDI -0.02
- Stochastic Oscillator
- FEBO 8.20
- CLDI 9.85
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.